Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells.
Troiani T, Vecchione L, Martinelli E, Capasso A, Costantino S, Ciuffreda LP, Morgillo F, Vitagliano D, D'Aiuto E, De Palma R, Tejpar S, Van Cutsem E, De Lorenzi M, Caraglia M, Berrino L, Ciardiello F.
Troiani T, et al. Among authors: van cutsem e.
Br J Cancer. 2012 May 8;106(10):1648-59. doi: 10.1038/bjc.2012.129.
Br J Cancer. 2012.
PMID: 22569000
Free PMC article.